Riskpilot← Back to searchSign inGet full accessDermaSpace ApS
APSActiveCVR 39593777Niels Bohrs Vej 21Wholesale of perfume and cosmetics · NACE 4645Est. 201836 employees
Revenue 2024
DKK 14,2M
+156% vs 2023
EBITDA margin
66.1%
+143% vs 2023
Equity ratio
29.3%
Financial strength
Net profit 2024
DKK 6,3M
+126% vs 2023
| Revenue | DKK 14,2M | +156% |
| EBITDA | DKK 9,4M | +143% |
| Net profit | DKK 6,3M | +126% |
| Total assets | DKK 33,1M | +270% |
| Equity | DKK 9,7M | +232% |
| Employees | 36 | — |
Legal name
DermaSpace ApS
CVR number
39593777
Legal form
Anpartsselskab
NACE code
4645 · Wholesale of perfume and cosmetics
Founded
25. maj 2018
Share capital
DKK 50.000
Employees
36 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør eller af den samlede bestyrelse i forening.
Company purpose
Selskabets formål er at foretage køb af varer med det formål at sælge dem videre til slutbrugere (detailsalg); at foretage køb af varer med det formål at sælge dem videre til andre mellemmænd (engrossalg); at deltage i samarbejde og andre ydelser relateret til salg og distribuering af varer og hermed forbundet virksomhed.
Address
Niels Bohrs Vej 21
Phone
+4542480700
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 30 | 131 | 617 | 1.012 | 1.262 | 5.535 | 14.185 |
| Staff expenses | -15 | -74 | -156 | -1.168 | -1.259 | -1.681 | -4.804 |
| EBITDA | 15 | 57 | 462 | -156 | 3 | 3.853 | 9.381 |
| Depreciation & amort. | -13 | -13 | -13 | -13 | -118 | -119 | -117 |
| EBIT | 2 | 44 | 449 | -169 | -115 | 3.735 | 9.265 |
| Net financials | -2 | -12 | -12 | -20 | -35 | -191 | -1.224 |
| Profit before tax | 0 | 32 | 437 | -189 | -150 | 3.544 | 8.041 |
| Tax | 0 | 7 | 96 | -42 | -36 | 781 | 1.787 |
| Net profit | 0 | 25 | 340 | -147 | -115 | 2.763 | 6.253 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 257 | 456 | 1.584 | 2.197 | 2.298 | 8.961 | 33.142 |
| Equity | 50 | 75 | 415 | 268 | 154 | 2.917 | 9.695 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 2.700 |
| Short-term debt | 206 | 376 | 1.166 | 1.929 | 2.144 | 6.028 | 20.747 |
| Total debt | 206 | 376 | 1.166 | 1.929 | 2.144 | 6.028 | 23.447 |
EBITDA margin
66.1%
This company
15.8%
Market median
+318% vs market
20182024
Equity ratio
29.3%
This company
38.2%
Market median
-23% vs market
20182024
Return on equity
64.5%
This company
18.4%
Market median
+251% vs market
20182024
Net profit margin
44.1%
This company
8.1%
Market median
+444% vs market
20182024
Asset turnover
0.43×
This company
1.12×
Market median
-62% vs market
20182024
Debt / equity
2.42×
This company
0.62×
Market median
-290% vs market
20182024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-05-25 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MM Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2025 | — | — | |
| Board of Directors | 2026 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Mette Vernegaard Holding ApS | Company | 50.0% | 50.0% | 2024 |
Katrine Vernegaard Holding ApS | Company | 50.0% | 50.0% | 2024 |
DermaSpace Holding ApS | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mette Vernegaard Holding ApS
DermaSpace ApS Board members of DermaSpace ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mette Marckmann Vernegaard | Chief Executive Officer | 0 companies |
| Sune Fraes Diernæs | Chairman | 0 companies |
| Katrine Marckmann Vernegaard | Board of Directors | 0 companies |